Skip to content
COMPANY
PRODUCTS
R & D
Product Candidates Overview
Pipeline
Orphan Drug Designations
PARTNERING
INVESTOR RELATIONS
Press Releases
Events & Presentations
Stock Information
SEC Filings
XBRL Filings
Stockholder Meeting
Corporate Governance
Email Alerts
Investor Contact
BLOG
CONTACT
Press Releases
Apr 18, 2002
Hemispherx and The AIDS Community Research Initiative of America -- ACRIA -- Launch Immunotherapeutic HIV/AIDS Clinical Trials in New York City
Apr 08, 2002
Hemispherx Announces Fourth Quarter and Full Year Results
Apr 02, 2002
Hemispherx to Present Today At 1:30 PM On the American Stock Exchange Invitation On Line Conference
Mar 26, 2002
Hemispherx Biopharma Launches New Website
Mar 19, 2002
Hemispherx Disseminates New Clinical Data on Experimental Treatment of Multi-Drug Resistant HIV/AIDS Virus Virus Levels Observed to Drop
Mar 18, 2002
Hemispherx Announces Poly I:Poly C12U Increases the Control of HIV During Strategic Treatment Interruption in Chronically HIV Infected Patients
Feb 27, 2002
Hemispherx to Present New Clinical Data on Experimental Treatment of Multi-Resistant HIV/AIDS Virus
Feb 22, 2002
Hemispherx Defamation Trial Results in Claims of Both Parties Being Denied Jury Fails To Award Damages Against Asensio;
Jan 28, 2002
Hemispherx Continues To Enroll New Clinical Investigators And Expand Clinical Trial Sites In HIV Trials Company Also Prepares To Present At Upcoming Scientific Conferences
Dec 04, 2001
Hemispherx Comments on New Report From U.S. Agency for Healthcare Research and Quality -- AHRQ -- on Chronic Fatique Syndrome -- CFS --
76
77
78
79
80
81
82
<<
<
>
>>
Privacy